Galapagos NV (AMS:GLPG)
24.62
+0.30 (1.23%)
May 6, 2026, 5:36 PM CET
Galapagos NV Revenue
Galapagos NV had revenue of 6.48M EUR in the quarter ending March 31, 2026, a decrease of -91.36%. This brings the company's revenue in the last twelve months to 1.04B, up 262.17% year-over-year. In the year 2025, Galapagos NV had annual revenue of 1.11B with 303.50% growth.
Revenue (ttm)
1.04B
Revenue Growth
+262.17%
P/S Ratio
1.46
Revenue / Employee
1.58M
Employees
558
Market Cap
1.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.11B | 836.60M | 303.50% |
| Dec 31, 2024 | 275.65M | 35.93M | 14.99% |
| Dec 31, 2023 | 239.72M | -1.53M | -0.63% |
| Dec 31, 2022 | 241.25M | 85.33M | 54.73% |
| Dec 31, 2017 | 155.92M | 4.31M | 2.84% |
| Dec 31, 2016 | 151.61M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke BAM Groep nv | 7.04B |
| Signify | 5.59B |
| Havas | 2.91B |
| Koninklijke Heijmans | 2.77B |
| Fugro | 1.85B |
| TKH Group | 1.76B |
| AMG Critical Materials | 1.45B |
| Basic-Fit | 1.42B |
Galapagos NV News
- 8 hours ago - Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 days ago - Oversold Conditions For Galapagos (GLPG) - Nasdaq
- 8 days ago - Galapagos NV: Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 - Finanz Nachrichten
- 8 days ago - Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 - GlobeNewsWire
- 5 weeks ago - Galapagos NV Transcript: Collaboration - Transcripts
- 5 weeks ago - Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal - Nasdaq
- 5 weeks ago - Galapagos NV: Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - Finanz Nachrichten
- 5 weeks ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire